DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $2,021,000 | -36.8% | 505,364 | -21.9% | 0.41% | -40.1% |
| Q3 2019 | $3,196,000 | -14.0% | 646,811 | +6.0% | 0.69% | -15.2% |
| Q2 2019 | $3,718,000 | +16.0% | 610,367 | +10.6% | 0.82% | +13.0% |
| Q1 2019 | $3,204,000 | -46.7% | 551,620 | +23.6% | 0.72% | -48.2% |
| Q4 2018 | $6,007,000 | – | 446,288 | – | 1.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SENZAR ASSET MANAGEMENT, LLC | 445,200 | $7,101,000 | 1.80% |
| Redmile Group, LLC | 1,254,342 | $20,007,000 | 1.30% |
| Irving Magee Investment Management | 166,505 | $2,656,000 | 1.02% |
| BROADVIEW ADVISORS LLC | 376,050 | $5,998,000 | 0.83% |
| Sivik Global Healthcare LLC | 101,000 | $1,611,000 | 0.75% |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 5,455,461 | $87,015,000 | 0.64% |
| Iguana Healthcare Management, LLC | 75,000 | $1,196,000 | 0.59% |
| RIVERBRIDGE PARTNERS LLC | 1,464,286 | $23,355,000 | 0.47% |
| HERMES INVESTMENT MANAGEMENT LTD | 1,772,777 | $28,276,000 | 0.46% |
| Endurant Capital Management LP | 85,043 | $1,356,000 | 0.44% |